AIM
AIM ImmunoTech
30 hedge funds and large institutions have $2.43M invested in AIM ImmunoTech in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$120K | |
| 2 | +$84.1K | |
| 3 | +$21K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17.2K |
| 5 |
VF
Virtu Financial
New York
|
+$15.3K |
Top Sellers
| 1 | -$46.6K | |
| 2 | -$26K | |
| 3 | -$7.45K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.83K |